DE2452907A1 - Tierzuchtmittel - Google Patents
TierzuchtmittelInfo
- Publication number
- DE2452907A1 DE2452907A1 DE19742452907 DE2452907A DE2452907A1 DE 2452907 A1 DE2452907 A1 DE 2452907A1 DE 19742452907 DE19742452907 DE 19742452907 DE 2452907 A DE2452907 A DE 2452907A DE 2452907 A1 DE2452907 A1 DE 2452907A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- carbon atoms
- steroid
- contain
- animal breeding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000003975 animal breeding Methods 0.000 title claims description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims description 51
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 22
- 241001465754 Metazoa Species 0.000 claims description 21
- 150000003431 steroids Chemical class 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 239000003263 anabolic agent Substances 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 10
- 229960005309 estradiol Drugs 0.000 claims description 10
- 229930182833 estradiol Natural products 0.000 claims description 10
- 229940011871 estrogen Drugs 0.000 claims description 10
- 239000000262 estrogen Substances 0.000 claims description 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 9
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 6
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 4
- 229940126601 medicinal product Drugs 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- -1 cyclic carboxylic acid Chemical class 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000005429 oxyalkyl group Chemical group 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 230000001195 anabolic effect Effects 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 239000012876 carrier material Substances 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 244000309466 calf Species 0.000 description 6
- 239000007943 implant Substances 0.000 description 6
- 235000019786 weight gain Nutrition 0.000 description 6
- 230000004584 weight gain Effects 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- YVHAIVPPUIZFBA-UHFFFAOYSA-N Cyclopentylacetic acid Chemical compound OC(=O)CC1CCCC1 YVHAIVPPUIZFBA-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 4
- LJOODBDWMQKMFB-UHFFFAOYSA-N cyclohexylacetic acid Chemical compound OC(=O)CC1CCCCC1 LJOODBDWMQKMFB-UHFFFAOYSA-N 0.000 description 4
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- AMOJMSPUYHSMKI-UHFFFAOYSA-N 2-cyclopropylpropanoic acid Chemical compound OC(=O)C(C)C1CC1 AMOJMSPUYHSMKI-UHFFFAOYSA-N 0.000 description 2
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 206010054949 Metaplasia Diseases 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000015689 metaplastic ossification Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- KVVDRQDTODKIJD-UHFFFAOYSA-N 2-cyclopropylacetic acid Chemical compound OC(=O)CC1CC1 KVVDRQDTODKIJD-UHFFFAOYSA-N 0.000 description 1
- PLTVGIMYBBJWJZ-QYZOEREBSA-N CC[C@@]12CCC[C@H]1[C@@H]1CCC3=CCCCC3=C1C=C2 Chemical compound CC[C@@]12CCC[C@H]1[C@@H]1CCC3=CCCCC3=C1C=C2 PLTVGIMYBBJWJZ-QYZOEREBSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- HJZLEGIHUQOJBA-UHFFFAOYSA-N cyclohexane propionic acid Chemical compound OC(=O)CCC1CCCCC1 HJZLEGIHUQOJBA-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 235000021051 daily weight gain Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 229940071886 estradiol 20 mg Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000019180 nutritional disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/168—Steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7339845A FR2250518B1 (enExample) | 1973-11-09 | 1973-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2452907A1 true DE2452907A1 (de) | 1975-05-15 |
Family
ID=9127503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19742452907 Ceased DE2452907A1 (de) | 1973-11-09 | 1974-11-07 | Tierzuchtmittel |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5075864A (enExample) |
| AR (1) | AR208185A1 (enExample) |
| BE (1) | BE821944A (enExample) |
| BR (1) | BR7409405A (enExample) |
| CA (1) | CA1033297A (enExample) |
| CH (1) | CH603070A5 (enExample) |
| DE (1) | DE2452907A1 (enExample) |
| DK (1) | DK581974A (enExample) |
| FR (1) | FR2250518B1 (enExample) |
| GB (1) | GB1457339A (enExample) |
| HU (1) | HU171037B (enExample) |
| IE (1) | IE40540B1 (enExample) |
| IT (1) | IT1059695B (enExample) |
| NL (1) | NL7414581A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4057561A (en) * | 1976-02-23 | 1977-11-08 | Hoffmann-La Roche Inc. | D-Homo-19-norsteroids |
-
1973
- 1973-11-09 FR FR7339845A patent/FR2250518B1/fr not_active Expired
-
1974
- 1974-01-01 AR AR256444A patent/AR208185A1/es active
- 1974-11-07 BE BE150289A patent/BE821944A/xx not_active IP Right Cessation
- 1974-11-07 DE DE19742452907 patent/DE2452907A1/de not_active Ceased
- 1974-11-08 CH CH1499574A patent/CH603070A5/xx not_active IP Right Cessation
- 1974-11-08 HU HU74RO00000808A patent/HU171037B/hu unknown
- 1974-11-08 IE IE2303/74A patent/IE40540B1/xx unknown
- 1974-11-08 DK DK581974A patent/DK581974A/da unknown
- 1974-11-08 BR BR9405/74A patent/BR7409405A/pt unknown
- 1974-11-08 JP JP49128166A patent/JPS5075864A/ja active Pending
- 1974-11-08 NL NL7414581A patent/NL7414581A/xx not_active Application Discontinuation
- 1974-11-08 GB GB4851274A patent/GB1457339A/en not_active Expired
- 1974-11-08 IT IT53950/74A patent/IT1059695B/it active
- 1974-11-08 CA CA213,405A patent/CA1033297A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4057561A (en) * | 1976-02-23 | 1977-11-08 | Hoffmann-La Roche Inc. | D-Homo-19-norsteroids |
Also Published As
| Publication number | Publication date |
|---|---|
| IE40540B1 (en) | 1979-06-20 |
| BR7409405A (pt) | 1976-05-18 |
| FR2250518B1 (enExample) | 1977-04-22 |
| BE821944A (fr) | 1975-05-07 |
| AR208185A1 (es) | 1976-12-09 |
| HU171037B (hu) | 1977-10-28 |
| CH603070A5 (enExample) | 1978-08-15 |
| AU7518074A (en) | 1976-05-13 |
| FR2250518A1 (enExample) | 1975-06-06 |
| NL7414581A (nl) | 1975-05-13 |
| CA1033297A (en) | 1978-06-20 |
| DK581974A (enExample) | 1975-07-07 |
| GB1457339A (en) | 1976-12-01 |
| IE40540L (en) | 1975-05-09 |
| JPS5075864A (enExample) | 1975-06-21 |
| IT1059695B (it) | 1982-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1935423A2 (de) | Zusammensetzung zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen | |
| DE2953334C1 (de) | 3-(2,2,2-Trimethylhydrazinium)propionat,Verfahren zu dessen Herstellung und Futtermittel,welche dieses enthalten | |
| EP0281778A1 (de) | Mehrteilige implantierbare Arzneizubereitung mit Langzeitwirkung | |
| DE2618129A1 (de) | Feste, subkutan implantierbare pille, enthaltend eine biologisch wirksame menge an 2 alpha-methylandrostan-17beta- 0l-3-on-17-propionat, verfahren zu deren herstellung und anwendung | |
| DE3876963T2 (de) | Tablette für Haustiere. | |
| DE2818586C2 (enExample) | ||
| EP1753408B1 (de) | Hormonales kontrazeptivum enthaltend eine kombination aus ethinylestradiol und chlormadinonacetat | |
| DE69721462T2 (de) | Verfahren zur Förderung von Ovulation und Geburt bei Säugetieren | |
| DE2729824A1 (de) | Pharmazeutische zusammensetzungen mit organischen montmorillonit-derivaten und ihre herstellung | |
| DE2149744A1 (de) | 19-Nor-sprioxenon als anabolisches Mittel | |
| DE69115745T2 (de) | Verwendung von Steroidderivaten zur Behandlung der Endometriose | |
| DE2449653C2 (de) | Tiermastmittel | |
| DE1302401C2 (de) | Knorpelmasse | |
| DE2452907A1 (de) | Tierzuchtmittel | |
| DE2323615C2 (enExample) | ||
| DE2633891C2 (de) | Tris-(hydroxymethyl)-aminomethansalz der 2-(5-Benzoylthienyl)-α-methylessigsäure, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen | |
| DE2720288C2 (de) | Verwendung von Magnesiumsalzen zur Herstellung von Zubereitungen zur Behandlung von Nutztieren | |
| DE1617450A1 (de) | Verfahren zur Verbesserung der Konzeptionsrate von weiblichen Haussaeugetieren | |
| DE3931693C2 (enExample) | ||
| DE1617601B2 (de) | Arzneimittel zur behandlung der prostatahypertrophie | |
| DE3242446A1 (de) | Biologisches mittel zur regeneration der haare und der haut | |
| DE69423016T2 (de) | Verfahren zur Steigerung der Gewichtszunahme von Säugetieren | |
| DE3132817C2 (enExample) | ||
| DE69426149T2 (de) | Ecdysone zur verbesserung der produktivität von wiederkäuern | |
| DE1940096A1 (de) | Verfahren zur Erhoehung der Traechtigkeitsrate und der Lebendgeburten bei Kuehen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8131 | Rejection |